Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Conflicting advice on use of aspirin

I read the recent 'Tip of the week' on your clinical round-up page, which 'reiterates recent advice that low-dose aspirin should be limited to patients with established cardiovascular disease and avoided in patients simply at high risk, such as those with hypertension and diabetes'

However, I note the Guidelines in Action 19, discussing the management of newer agents in patients with diabetes, advises use of aspirin as a primary prevention measure. It would appear there will be some confusion about this until current diabetes guidelines are updated.

From Dr Jan Yazici

Stockport, Cheshire

Editor's note

Dr Yazici is quite right to note that there is confusion on this matter. The MHRA and SIGN have both updated their guidance to advise against routine use of aspirin for primary prevention, but an update to NICE guidance is still pending.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say